DK1349580T4 - Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning - Google Patents

Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning

Info

Publication number
DK1349580T4
DK1349580T4 DK01985427.2T DK01985427T DK1349580T4 DK 1349580 T4 DK1349580 T4 DK 1349580T4 DK 01985427 T DK01985427 T DK 01985427T DK 1349580 T4 DK1349580 T4 DK 1349580T4
Authority
DK
Denmark
Prior art keywords
stability
improving
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK01985427.2T
Other languages
English (en)
Other versions
DK1349580T3 (da
Inventor
Andrea Fetz
Gyoergy Lajos Kis
Michel Pepiot
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1349580(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1349580T3 publication Critical patent/DK1349580T3/da
Publication of DK1349580T4 publication Critical patent/DK1349580T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/081—Gamma radiation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2/206—Ethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01985427.2T 2000-12-22 2001-12-20 Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning DK1349580T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128318 2000-12-22
PCT/EP2001/015126 WO2002051452A1 (en) 2000-12-22 2001-12-20 Process to improve stability of a pharmaceutical composition

Publications (2)

Publication Number Publication Date
DK1349580T3 DK1349580T3 (da) 2007-10-01
DK1349580T4 true DK1349580T4 (da) 2012-10-08

Family

ID=8170784

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01985427.2T DK1349580T4 (da) 2000-12-22 2001-12-20 Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning

Country Status (15)

Country Link
US (4) US20040063607A1 (da)
EP (1) EP1349580B2 (da)
JP (1) JP4125957B2 (da)
CN (1) CN100396334C (da)
AR (1) AR032381A1 (da)
AT (1) ATE367831T1 (da)
BR (1) BRPI0116332B8 (da)
CA (1) CA2431906A1 (da)
CY (1) CY1106919T1 (da)
DE (1) DE60129597T3 (da)
DK (1) DK1349580T4 (da)
ES (1) ES2287173T5 (da)
PT (1) PT1349580E (da)
TW (1) TW586946B (da)
WO (1) WO2002051452A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
JP4694773B2 (ja) * 2003-06-06 2011-06-08 ロート製薬株式会社 粘膜適用液状組成物
WO2005011704A1 (ja) * 2003-07-31 2005-02-10 Santen Pharmaceutical Co., Ltd. プロスタグランジン含有製品
CN102526064A (zh) * 2004-12-09 2012-07-04 参天制药株式会社 含有分子内具有氟原子的前列腺素的制品
WO2006068266A1 (ja) * 2004-12-24 2006-06-29 Santen Pharmaceutical Co., Ltd. プロスタグランジンＦ２ａ誘導体含有製品
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
KR101454674B1 (ko) 2006-03-17 2014-10-27 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물
WO2008040488A1 (en) 2006-10-04 2008-04-10 M & P Patent Aktiengesellschaft Controlled release delivery system for nasal application of neurotransmitters
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
CA2749352A1 (en) * 2009-02-20 2010-09-10 Micro Labs Limited Storage stable prostaglandin product
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
EP2269575A1 (en) 2009-06-30 2011-01-05 Santen Pharmaceutical Co., Ltd Method for improving bioavailability of latanoprost
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
JP2015515480A (ja) * 2012-04-19 2015-05-28 シー・アール・バード・インコーポレーテッドＣ Ｒ Ｂａｒｄ Ｉｎｃｏｒｐｏｒａｔｅｄ エチレンオキシド滅菌下のｐＨ安定性が改善された注入液
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
JP6427843B2 (ja) 2013-03-29 2018-11-28 株式会社ＡｓｋＡｔ 眼疾患治療剤
JP7037349B2 (ja) * 2017-06-23 2022-03-16 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
WO2018235935A1 (ja) * 2017-06-23 2018-12-27 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
JPWO2019026992A1 (ja) * 2017-08-03 2020-06-18 参天製薬株式会社 クロルヘキシジンを含有する医薬組成物
MX388336B (es) * 2019-09-06 2025-03-19 Sophia Holdings S A De C V Composicion farmacéutica oftálmica, procesos de preparación y usos de las mismas
KR20230041680A (ko) 2020-07-16 2023-03-24 라퀄리아 파마 인코포레이티드 안구 질환 치료제로서의 trpv4 억제제
US20240156724A1 (en) * 2021-03-16 2024-05-16 Vyluma Inc. Multi-Dose Container for Ophthalmic Compositions
US12233049B2 (en) * 2021-11-15 2025-02-25 Slayback Pharma Llc Stable pharmaceutical compositions of clonidine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE523577A (da) * 1952-10-16
GB1107600A (en) † 1965-12-15 1968-03-27 U M P Venesta Ltd Improvements relating to collapsible tubular containers
CH483963A (fr) * 1968-01-11 1970-01-15 U M P Venesta Ltd Récipient tubulaire souple
NL7009539A (da) * 1969-07-07 1971-01-11
US3728839A (en) * 1971-04-29 1973-04-24 American Cyanamid Co Storage stable surgically absorbable polyglycolic acid products
US4482585A (en) * 1982-06-11 1984-11-13 Toppan Printing Co., Ltd. Container resistant to extremely low temperatures
US5382406A (en) * 1990-04-17 1995-01-17 Abbott Laboratories Sterile filling method
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
US5620425A (en) * 1993-11-03 1997-04-15 Bracco International B.V. Method for the preparation of pre-filled plastic syringes
US5749203A (en) * 1994-09-23 1998-05-12 Kimberly-Clark Corporation Method of packaging a medical article
SE515221C2 (sv) * 1996-03-20 2001-07-02 Scandimed Internat Ab Förfarande för framställning av och anordning vid en förpackning med en sterilt förpackad behållare med sterilt innehåll
US6132679A (en) * 1997-12-24 2000-10-17 Alliedsignal, Inc. Method and apparatus for aerating chemically-sterilized articles
AU2042200A (en) * 1998-12-07 2000-06-26 Baylor College Of Medicine Preventing and removing biofilm from the surface of medical devices
US6440364B1 (en) † 1999-02-16 2002-08-27 Ethicon, Inc. Method of degassing absorbable suture products
US6231810B1 (en) * 1999-04-21 2001-05-15 Stryker Technologies Corporation Special cycle for ethylene oxide sterilization
PT1352837E (pt) * 1999-05-28 2006-06-30 Novartis Ag Processo para fabricacao de uma embalagem compressivel esterilizada para um produto farmaceutico

Also Published As

Publication number Publication date
US20130097969A1 (en) 2013-04-25
ES2287173T5 (es) 2012-10-03
CN1481259A (zh) 2004-03-10
US20080300277A1 (en) 2008-12-04
CA2431906A1 (en) 2002-07-04
JP2004516099A (ja) 2004-06-03
DE60129597D1 (de) 2007-09-06
EP1349580B1 (en) 2007-07-25
ATE367831T1 (de) 2007-08-15
DE60129597T3 (de) 2012-11-29
AR032381A1 (es) 2003-11-05
BR0116332B1 (pt) 2014-08-19
CN100396334C (zh) 2008-06-25
DE60129597T2 (de) 2008-04-17
EP1349580A1 (en) 2003-10-08
US20040063607A1 (en) 2004-04-01
BR0116332A (pt) 2004-03-02
CY1106919T1 (el) 2012-09-26
BRPI0116332B8 (pt) 2021-06-22
EP1349580B2 (en) 2012-07-04
ES2287173T3 (es) 2007-12-16
DK1349580T3 (da) 2007-10-01
US20110173928A1 (en) 2011-07-21
JP4125957B2 (ja) 2008-07-30
WO2002051452A1 (en) 2002-07-04
PT1349580E (pt) 2007-10-25
TW586946B (en) 2004-05-11

Similar Documents

Publication Publication Date Title
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1349580T3 (da) Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1253153T3 (da) Fremgangsmåde til fremstilling af 4"-substituerede-9-deoxo-9a-aza-9a-homoerythromycin-A-derivater
DK1524266T3 (da) Farmaceutisk sammensætning
DK1309581T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1383482T3 (da) Fremgangsmåde til fremstilling af en farmaceutisk lavdoseringssammensætning
EE05020B1 (et) Glburiidi ravimkoostis
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1263717T3 (da) Fremgangsmåde til fremstilling af methionin
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1446107T3 (da) Fremgangsmåde til fremstilling af tabletter omfattende s-adenosylmethionin
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1300160T3 (da) Fremgangsmåde til stabilisering af en sammensætning
DK1041081T3 (da) Fremgangsmåde til fremstilling af et præparat med höjt gangliosidindhold
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin